$NRXP

$3.31▲ -5.2% YTD

3 SEC 13D/G filings tracked · Last updated Sep 15, 2026

Filing History

NRXP ▼ -5.2% - NRx Pharmaceuticals, Inc.

CP $3.31▲ -5.2%Sep 15, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ke…

News

NRXP ▼ -0.3% - NRx Pharmaceuticals, Inc.

CP $3.39▲ -0.3%Sep 14, 2026 · ThinkSabio Blog

$NRXP - GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral…

News

NRXP ▼ -1.2% - NRx Pharmaceuticals, Inc.

CP $3.36▲ -1.2%Sep 11, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS Syst…